Cargando…
Evolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted Therapies
Multiple myeloma (MM) is a clonal plasma cell disorder defined by bone marrow infiltration and osteolytic bone lesions and is the second most common hematologic malignancy after non-Hodgkin lymphoma. The landscape of MM treatment was transformed at the dawn of the twenty-first century by the introdu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837942/ https://www.ncbi.nlm.nih.gov/pubmed/27182478 http://dx.doi.org/10.1007/s40487-015-0009-4 |